Insider Trading Alert - IRM, RMD And AMTD Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Yesterday, Sept. 9, 2014, 75 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $46.83 to $226,304,343.30.

Highlighted Stocks Traded by Insiders:

Iron Mountain (IRM) - FREE Research Report

Deninger Paul F, who is Director at Iron Mountain, bought 14,000 shares at $35.92 on Sept. 9, 2014. Following this transaction, the Director owned 30,008 shares meaning that the stake was boosted by 87.46% with the 14,000-share transaction.

The shares most recently traded at $35.84, down $0.08, or 0.22% since the insider transaction. Historical insider transactions for Iron Mountain go as follows:

  • 24-Week # shares bought: 21,400

The average volume for Iron Mountain has been 1.7 million shares per day over the past 30 days. Iron Mountain has a market cap of $7.0 billion and is part of the technology sector and computer software & services industry. Shares are up 17.36% year-to-date as of the close of trading on Tuesday.

Iron Mountain Incorporated, together with its subsidiaries, provides storage and information management services primarily in North America, Europe, Latin America, and the Asia Pacific. The stock currently has a dividend yield of 2.98%. The company has a P/E ratio of 18.9. Currently, there are 4 analysts who rate Iron Mountain a buy, 1 analyst rates it a sell, and 5 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on IRM - FREE

TheStreet Quant Ratings rates Iron Mountain as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, notable return on equity, solid stock price performance, compelling growth in net income and good cash flow from operations. We feel these strengths outweigh the fact that the company has had generally high debt management risk by most measures that we evaluated. Get the full Iron Mountain Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

ResMed (RMD) - FREE Research Report

Sandercock Brett, who is Chief Financial Officer at ResMed, sold 10,000 shares at $52.99 on Sept. 9, 2014. Following this transaction, the Chief Financial Officer owned 60,913 shares meaning that the stake was reduced by 14.1% with the 10,000-share transaction.

The shares most recently traded at $52.43, down $0.56, or 1.06% since the insider transaction. Historical insider transactions for ResMed go as follows:

  • 4-Week # shares sold: 10,000
  • 12-Week # shares sold: 10,000
  • 24-Week # shares sold: 44,290

The average volume for ResMed has been 849,700 shares per day over the past 30 days. ResMed has a market cap of $7.4 billion and is part of the health care sector and health services industry. Shares are up 11.51% year-to-date as of the close of trading on Tuesday.

ResMed Inc. develops, manufactures, distributes, and markets medical equipment for the diagnosis, treatment, and management of respiratory disorders, with a focus on sleep-disordered breathing. The stock currently has a dividend yield of 2.12%. The company has a P/E ratio of 22.1. Currently, there are 4 analysts who rate ResMed a buy, 1 analyst rates it a sell, and 4 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on RMD - FREE

TheStreet Quant Ratings rates ResMed as a buy. The company's strengths can be seen in multiple areas, such as its growth in earnings per share, increase in net income, revenue growth, largely solid financial position with reasonable debt levels by most measures and notable return on equity. We feel these strengths outweigh the fact that the company shows weak operating cash flow. Get the full ResMed Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

TD Ameritrade (AMTD) - FREE Research Report

Tomczyk Fredric J, who is President and CEO at TD Ameritrade, sold 75,000 shares at $32.60 on Sept. 9, 2014. Following this transaction, the President and CEO owned 1.0 million shares meaning that the stake was reduced by 6.67% with the 75,000-share transaction.

The shares most recently traded at $32.64, up $0.04, or 0.13% since the insider transaction. Historical insider transactions for TD Ameritrade go as follows:

  • 4-Week # shares sold: 3.0 million
  • 12-Week # shares sold: 3.1 million
  • 24-Week # shares sold: 3.1 million

The average volume for TD Ameritrade has been 2.3 million shares per day over the past 30 days. TD Ameritrade has a market cap of $17.8 billion and is part of the financial sector and financial services industry. Shares are up 6.2% year-to-date as of the close of trading on Tuesday.

TD Ameritrade Holding Corporation provides securities brokerage services and technology-based financial services to retail investors, traders, and independent registered investment advisors (RIAs) in the United States. The stock currently has a dividend yield of 1.47%. The company has a P/E ratio of 23.3. Currently, there are 12 analysts who rate TD Ameritrade a buy, no analysts rate it a sell, and 3 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on AMTD - FREE

TheStreet Quant Ratings rates TD Ameritrade as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, notable return on equity, expanding profit margins, good cash flow from operations and solid stock price performance. Although the company may harbor some minor weaknesses, we feel they are unlikely to have a significant impact on results. Get the full TD Ameritrade Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

null

More from Markets

Trump Takes Aim at Auto Imports; Markets End Mixed -- ICYMI

Trump Takes Aim at Auto Imports; Markets End Mixed -- ICYMI

Video: What Oprah's Content Partnership With Apple Means for the Rest of Tech

Video: What Oprah's Content Partnership With Apple Means for the Rest of Tech

REPLAY: Jim Cramer on the Markets, Oil, Starbucks, Tesla, Okta and Red Hat

REPLAY: Jim Cramer on the Markets, Oil, Starbucks, Tesla, Okta and Red Hat

Flashback Friday: The Market Movers

Flashback Friday: The Market Movers

OPEC Deal Doesn't Boost Production Enough to Drive Down Crude, Gasoline Prices

OPEC Deal Doesn't Boost Production Enough to Drive Down Crude, Gasoline Prices